29 August 2008
p53 codon 72 polymorphism and HPV status in lung cancer
Nur BuyruADEFG, Julide AltinisikBC, Mustafa IsinBC, Nejat DalayAEFMed Sci Monit 2008; 14(9): CR493-497 :: ID: 867968
Abstract
Background
Several risk factors, both environmental and genetic, have been associated with the pathogenesis of lung cancer. A common polymorphism at codon 72 of exon 4 of the p53 gene encoding either an arginine or proline has been shown to confer susceptibility to the development of different human malignancies. This polymorphism affects proteolytic degradation of p53 promoted by the HPV-E6 protein and represents a risk factor for human-papillomavirus-induced carcinogenesis.
Material and Method
A total of 65 patients with lung cancer were recruited into the study and 87 healthy subjects were used as the control group. The codon 72 polymorphism was determined by the PCR-RFLP method. Presence of human papillomavirus DNA was analyzed by polymerase chain reaction using MY09 and MY11 consensus primers and hybridization with HPV16 and HPV18 specific probes.
Results
The frequencies of the Arg and Pro alleles were 68.46% and 31.54% in lung cancer patients and 55.7% and 44.3% in the healthy control subjects, respectively. These differences were statistically significant. Human papillomavirus DNA was detected in the blood circulation of only 1 patient.
Conclusions
Our results suggest that the Arg/Arg genotype may represent a potential risk factor for the development of lung cancer independent of the HPV infection.
Keywords: Polymorphism, Genetic, Repressor Proteins - genetics, Papillomavirus Infections - pathology, Oncogene Proteins, Viral - genetics, Lung Neoplasms - virology, Genotype, Genetic Predisposition to Disease, Gene Frequency, Tumor Suppressor Protein p53 - genetics, DNA-Binding Proteins - genetics, DNA, Viral - blood, Codon - genetics, Aged, 80 and over
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






